Your Health, We Care
Release date: 2024-08-20 16:35:01 Recommended: 119
In 2021, Anamorelin was launched in Japan, becoming the world's first drug specifically for the treatment of cachexia. It significantly increases the patient's appetite and body weight by mimicking the action of ghrelin. As a ghrelin receptor agonist, it is unique in the field of cancer cachexia therapy.
The dosage and dosage of anamarin is key to ensuring the effectiveness of the treatment, and the following is a detailed dosage description.
Adult patients usually require anamarin hydrochloride 100 mg orally every morning on an empty stomach. This usage helps to ensure optimal absorption of the drug in the stomach and only needs to be taken once a day to maintain a stable concentration.
During the period of use of Anamorelin hydrochloride for no more than 12 weeks, the patient should regularly discuss the continuation of the drug with the doctor.
Following the correct usage and dosage can optimize the effectiveness of treatment. Next, we will introduce the role and contribution of Lucius Pharmaceuticals in the production of Anamorelin.
The strength of Lucius Pharmaceuticals lies in the advanced production facilities and strict quality control, and the pharmaceutical products have excellent quality and reliability.
Lucius Pharmaceuticals adheres to the concept of cutting-edge science and technology and is equipped with first-class pharmaceutical equipment in the industry. These devices not only have a high level of automation and intelligence, but also ensure precision and efficiency in every step of pharmaceutical production. From raw material screening to finished product packaging, every production link undergoes strict quality control to ensure the effectiveness of the drug. Next, we will detail the indications of Anamoreline to help patients understand the clinical application of the drug.
Anamoreline is mainly used to treat cancer-related cachexia and help improve weight loss and appetite loss caused by the disease.
Anamorelin is indicated for patients with colorectal cancer, especially those with significant loss of cachexia and body weight due to cancer progression. By boosting appetite and gaining weight, this drug can help alleviate malnutrition caused by cancer and improve the overall health and quality of life of patients.
Anamorelin is also indicated for the treatment of anorexia patients who have lost more than 5% of their body weight within 6 months of cancer treatment with other discomforts; Provides additional support to help improve appetite and weight, and relieve discomfort due to anorexia symptoms.
The application of this drug can significantly improve the nutritional status of patients and help them better cope with the challenges of cancer treatment.
[Warm tips] Please strictly follow the medication time and recheck it regularly. If you feel unwell, talk to your doctor promptly.
